<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.1//EN"
  "http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en">
<head>
<meta name="generator" content="jemdoc, see http://jemdoc.jaboc.net/" />
<meta http-equiv="Content-Type" content="text/html;charset=utf-8" />
<link rel="stylesheet" href="jemdoc.css" type="text/css" />
<title>Research</title>
</head>
<body>
<table summary="Table for page layout." id="tlayout">
<tr valign="top">
<td id="layout-menu">
<div class="menu-item"><a href="index.html">Home</a></div>
<div class="menu-item"><a href="bio.html">Biography</a></div>
<div class="menu-item"><a href="research.html" class="current">Research</a></div>
<div class="menu-item"><a href="pub.html">Publications</a></div>
<div class="menu-item"><a href="ads.html">Opportunities</a></div>
<div class="menu-item"><a href="contact.html">Contacts</a></div>
</td>
<td id="layout-content">
<div id="toptitle">
<h1>Research</h1>
</div>
<p>Various cell types in the human body contain an identical copy of the genome but express a distinct set of genes. 
The Vahedi laboratory endeavors to understand how does a genome guide a limited set of genes to be expressed at different levels 
in distinct cell types particularly in the immune system. Overwhelming evidence suggests that epigenomics instructs the unique gene 
expression program in each cell type. Epigenomics refers to packaging of DNA into chromatin and represents a highly plastic vehicle 
for specifying cellular regulatory states. The emergence of high throughput genomic technologies is providing biology with an explosion of 
new experimental data, quantitatively measuring various aspects of epigenome at a genome-wide scale. 
Vahedi's lab develops computational methods to integrate diverse high throughput data and unravel a holistic systems level view of cells in the immune system.</p>
<p>Specific research directions are: (1) to delineate unique genomic regions (e.g. super-enhancers) from histone modification measurements using machine learning methods,
(2) to determine the impact of inflammatory bowel disease (IBD) genetic variants within enhancers of immune cells, (3) to reconstruct ontogenic lineage relationship during haematopoiesis using epigenomics measurements.</p>
<div id="footer">
<div id="footer-text">
Page generated 2015-02-22 08:59:46 EST, by <a href="http://jemdoc.jaboc.net/">jemdoc</a>.
</div>
</div>
</td>
</tr>
</table>
</body>
</html>
